ASCO GU 2024: immunotherapy highlights in kidney cancer

ASCO GU 2024: immunotherapy highlights in kidney cancer

GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni ChoueiriПодробнее

GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri

GU ASCO 2024 Highlights with Dr. Tian Zhang – CONTACT-02, BRCAAway, AMBASSADOR, Keynote-564Подробнее

GU ASCO 2024 Highlights with Dr. Tian Zhang – CONTACT-02, BRCAAway, AMBASSADOR, Keynote-564

2024 ASCO Genitourinary Kidney Cancer HighlightsПодробнее

2024 ASCO Genitourinary Kidney Cancer Highlights

ASCO GU 2024 highlights: BRCAAway, CONTACT-2 and KEYNOTE-564Подробнее

ASCO GU 2024 highlights: BRCAAway, CONTACT-2 and KEYNOTE-564

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023Подробнее

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023

RCC Highlights From ASCO® GU: Adjuvant Treatment, Immunotherapy, Toxicities, and MoreПодробнее

RCC Highlights From ASCO® GU: Adjuvant Treatment, Immunotherapy, Toxicities, and More